Differential metabolism of 4-hydroxynonenal in liver, lung and brain of mice and rats

Toxicology and Applied Pharmacology

Volumn 279, Issue 1, 2014, Pages 43-52

  Zheng, Ruijin ^b   Dragomir, Ana Cristina ^b   Mishin, Vladimir ^b   Richardson, Jason R ^a   Heck, Diane E ^c   Laskin, Debra L ^b   Laskin, Jeffrey D ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

4 Hydroxynonenal; Alcohol dehydrogenase; Lipid peroxidation; Neurotoxicity; Pulmonary toxicity; Reactive oxygen species

Indexed keywords

4 HYDROXYNONENAL; GLUTATHIONE TRANSFERASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; HOMOGENATE; LIPID PEROXIDATION; LIVER CELL; LIVER METABOLISM; LUNG FUNCTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN MODIFICATION; RAT; TISSUE INJURY; WESTERN BLOTTING;

4-HYDROXYNONENAL; ALCOHOL DEHYDROGENASE; LIPID PEROXIDATION; NEUROTOXICITY; PULMONARY TOXICITY; REACTIVE OXYGEN SPECIES;

ALDEHYDES; ANIMALS; ANTIBODIES, BLOCKING; BLOTTING, WESTERN; BRAIN; ENZYME INHIBITORS; GLUTATHIONE TRANSFERASE; HEPATOCYTES; KINETICS; LIVER; LUNG; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, LONG-EVANS; SPECIES SPECIFICITY; SUBCELLULAR FRACTIONS;

EID: 84902282525     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2014.04.026     Document Type: Article

References (60)

1. Alary J., Fernandez Y., Debrauwer L., Perdu E., Gueraud F. Identification of intermediate pathways of 4-hydroxynonenal metabolism in the rat. Chem. Res. Toxicol. 2003, 16:320-327.
2. Alary J., Gueraud F., Cravedi J.P. Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol. Asp. Med. 2003, 24:177-187.
3. Alin P., Danielson U.H., Mannervik B. 4-Hydroxyalk-2-enals are substrates for glutathione transferase. FEBS Lett. 1985, 179:267-270.
4. Amunom I., Dieter L.J., Tamasi V., Cai J., Conklin D.J., Srivastava S., Martin M.V., Guengerich F.P., Prough R.A. Cytochromes P450 catalyze the reduction of alpha, beta-unsaturated aldehydes. Chem. Res. Toxicol. 2011, 24:1223-1230.
5. Arunachalam G., Sundar I.K., Hwang J.W., Yao H., Rahman I. Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD. J. Inflamm. (Lond.) 2010, 7:34.
6. Bennaars-Eiden A., Higgins L., Hertzel A.V., Kapphahn R.J., Ferrington D.A., Bernlohr D.A. Covalent modification of epithelial fatty acid-binding protein by 4-hydroxynonenal in vitro and in vivo. Evidence for a role in antioxidant biology. J. Biol. Chem. 2002, 277:50693-50702.
7. Bergamini C.M., Gambetti S., Dondi A., Cervellati C. Oxygen, reactive oxygen species and tissue damage. Curr. Pharm. Des. 2004, 10:1611-1626.
8. Burczynski M.E., Sridhar G.R., Palackal N.T., Penning T.M. The reactive oxygen species- and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha, beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. J. Biol. Chem. 2001, 276:2890-2897.
9. Canuto R.A., Ferro M., Muzio G., Bassi A.M., Leonarduzzi G., Maggiora M., Adamo D., Poli G., Lindahl R. Role of aldehyde metabolizing enzymes in mediating effects of aldehyde products of lipid peroxidation in liver cells. Carcinogenesis 1994, 15:1359-1364.
10. Chen J.J., Yu B.P. Alterations in mitochondrial membrane fluidity by lipid peroxidation products. Free Radic. Biol. Med. 1994, 17:411-418.
11. Chen C.H., Ferreira J.C., Gross E.R., Mochly-Rosen D. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol. Rev. 2014, 94:1-34.
12. Cheng J.Z., Yang Y., Singh S.P., Singhal S.S., Awasthi S., Pan S.S., Singh S.V., Zimniak P., Awasthi Y.C. Two distinct 4-hydroxynonenal metabolizing glutathione S-transferase isozymes are differentially expressed in human tissues. Biochem. Biophys. Res. Commun. 2001, 282:1268-1274.
13. Crabb D.W., Matsumoto M., Chang D., You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proc. Nutr. Soc. 2004, 63:49-63.
14. Danielson U.H., Esterbauer H., Mannervik B. Structure-activity relationships of 4-hydroxyalkenals in the conjugation catalysed by mammalian glutathione transferases. Biochem. J. 1987, 247:707-713.
15. Dawidek-Pietryka K., Szczepaniak S., Dudka J., Mazur M. In vitro studies of human alcohol dehydrogenase inhibition in the process of methanol and ethylene glycol oxidation. Arch. Toxicol. 1998, 72:604-607.
16. Dick R.A., Kwak M.K., Sutter T.R., Kensler T.W. Antioxidative function and substrate specificity of NAD(P)H-dependent alkenal/one oxidoreductase. A new role for leukotriene B4 12-hydroxydehydrogenase/15-oxoprostaglandin 13-reductase. J. Biol. Chem. 2001, 276:40803-40810.
17. Dragomir A.C., Laskin J.D., Laskin D.L. Macrophage activation by factors released from acetaminophen-injured hepatocytes: potential role of HMGB1. Toxicol. Appl. Pharmacol. 2011, 253:170-177.
18. Engle M.R., Singh S.P., Czernik P.J., Gaddy D., Montague D.C., Ceci J.D., Yang Y., Awasthi S., Awasthi Y.C., Zimniak P. Physiological role of mGSTA4-4, a glutathione S-transferase metabolizing 4-hydroxynonenal: generation and analysis of mGsta4 null mouse. Toxicol. Appl. Pharmacol. 2004, 194:296-308.
19. Esterbauer H., Zollner H., Scholz N. Reaction of glutathione with conjugated carbonyls. Z. Naturforsch. C 1975, 30:466-473.
20. Esterbauer H., Zollner H., Lang J. Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions. Biochem. J. 1985, 228:363-373.
21. Flora S.J. Role of free radicals and antioxidants in health and disease. Cell Mol. Biol. (Noisy-le-grand) 2007, 53:1-2.
22. Forman H.J. Reactive oxygen species and alpha, beta-unsaturated aldehydes as second messengers in signal transduction. Ann. N. Y. Acad. Sci. 2010, 1203:35-44.
23. Galligan J.J., Smathers R.L., Fritz K.S., Epperson L.E., Hunter L.E., Petersen D.R. Protein carbonylation in a murine model for early alcoholic liver disease. Chem. Res. Toxicol. 2012, 25:1012-1021.
24. Hartley D.P., Petersen D.R. Metabolic interactions of 4-hydroxynonenal, acetaldehyde and glutathione in isolated liver mitochondria. Adv. Exp. Med. Biol. 1993, 328:27-36.
25. Hartley D.P., Ruth J.A., Petersen D.R. The hepatocellular metabolism of 4-hydroxynonenal by alcohol dehydrogenase, aldehyde dehydrogenase, and glutathione S-transferase. Arch. Biochem. Biophys. 1995, 316:197-205.
26. Hartley D.P., Kolaja K.L., Reichard J., Petersen D.R. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization. Toxicol. Appl. Pharmacol. 1999, 161:23-33.
27. Hollan S. Free radicals in health and disease. Haematologia (Budap) 1995, 26:177-189.
28. Honzatko A., Brichac J., Murphy T.C., Reberg A., Kubatova A., Smoliakova I.P., Picklo M.J. Enantioselective metabolism of trans-4-hydroxy-2-nonenal by brain mitochondria. Free Radic. Biol. Med. 2005, 39:913-924.
29. Houglum K., Filip M., Witztum J.L., Chojkier M. Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J. Clin. Invest. 1990, 86:1991-1998.
30. Kirichenko A., Li L., Morandi M.T., Holian A. 4-Hydroxy-2-nonenal-protein adducts and apoptosis in murine lung cells after acute ozone exposure. Toxicol. Appl. Pharmacol. 1996, 141:416-424.
31. Laurent A., Perdu-Durand E., Alary J., Debrauwer L., Cravedi J.P. Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol. Lett. 2000, 114:203-214.
32. Leonarduzzi G., Parola M., Muzio G., Garramone A., Maggiora M., Robino G., Poli G., Dianzani M.U., Canuto R.A. Hepatocellular metabolism of 4-hydroxy-2,3-nonenal is impaired in conditions of chronic cholestasis. Biochem. Biophys. Res. Commun. 1995, 214:669-675.
33. LoPachin R.M., Gavin T., Petersen D.R., Barber D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem. Res. Toxicol. 2009, 22:1499-1508.
34. Luckey S.W., Petersen D.R. Metabolism of 4-hydroxynonenal by rat Kupffer cells. Arch. Biochem. Biophys. 2001, 389:77-83.
35. Meyer M.J., Mosely D.E., Amarnath V., Picklo M.J. Metabolism of 4-hydroxy-trans-2-nonenal by central nervous system mitochondria is dependent on age and NAD+ availability. Chem. Res. Toxicol. 2004, 17:1272-1279.
36. Mitchell D.Y., Petersen D.R. The oxidation of alpha-beta unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol. 1987, 87:403-410.
37. Mitchell D.Y., Petersen D.R. Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase-mediated acetaldehyde oxidation by trans-4-hydroxy-2-nonenal. Hepatology 1991, 13:728-734.
38. Moreb J.S., Baker H.V., Chang L.J., Amaya M., Lopez M.C., Ostmark B., Chou W. ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Mol. Cancer 2008, 7:87.
39. Murphy T., Amarnath V., Picklo M.J. Oxidation of 4-hydroxynonenal in rat brain slices. Chem. Biol. Interact. 2003, 143-144:101-105.
40. Paradis V., Kollinger M., Fabre M., Holstege A., Poynard T., Bedossa P. In situ detection of lipid peroxidation by-products in chronic liver diseases. Hepatology 1997, 26:135-142.
41. Perluigi M., Sultana R., Cenini G., Di Domenico F., Memo M., Pierce W.M., Coccia R., Butterfield D.A. Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis. Proteomics Clin. Appl. 2009, 3:682-693.
42. Petersen D.R., Doorn J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic. Biol. Med. 2004, 37:937-945.
43. Poli G., Biasi F., Leonarduzzi G. 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol. Asp. Med. 2008, 29:67-71.
44. Poli G., Schaur R.J., Siems W.G., Leonarduzzi G. 4-Hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 2008, 28:569-631.
45. Rahman I., van Schadewijk A.A., Crowther A.J., Hiemstra P.S., Stolk J., MacNee W., De Boer W.I. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2002, 166:490-495.
46. Roede J.R., Stewart B.J., Petersen D.R. Hepatotoxicity of reactive aldehydes. Comprehensive, Toxicology 2010, 581-594. C.A. McQueen (Ed.).
47. Sidell K.R., Montine K.S., Picklo M.J., Olsen S.J., Amarnath V., Montine T.J. Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum. J. Neuropathol. Exp. Neurol. 2003, 62:146-153.
48. Siems W., Grune T. Intracellular metabolism of 4-hydroxynonenal. Mol. Asp. Med. 2003, 24:167-175.
49. Siems W.G., Zollner H., Grune T., Esterbauer H. Metabolic fate of 4-hydroxynonenal in hepatocytes: 1,4-dihydroxynonene is not the main product. J. Lipid Res. 1997, 38:612-622.
50. Sinclair A.J., Barnett A.H., Lunec J. Free radicals and antioxidant systems in health and disease. Br. J. Hosp. Med. 1990, 43:334-344.
51. Singhal S.S., Zimniak P., Awasthi S., Piper J.T., He N.G., Teng J.I., Petersen D.R., Awasthi Y.C. Several closely related glutathione S-transferase isozymes catalyzing conjugation of 4-hydroxynonenal are differentially expressed in human tissues. Arch. Biochem. Biophys. 1994, 311:242-250.
52. Smathers R.L., Galligan J.J., Stewart B.J., Petersen D.R. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem. Biol. Interact. 2011, 192:107-112.
53. Spitz D.R., Sullivan S.J., Malcolm R.R., Roberts R.J. Glutathione dependent metabolism and detoxification of 4-hydroxy-2-nonenal. Free Radic. Biol. Med. 1991, 11:415-423.
54. Srivastava S., Dixit B.L., Cai J., Sharma S., Hurst H.E., Bhatnagar A., Srivastava S.K. Metabolism of lipid peroxidation product, 4-hydroxynonenal (HNE) in rat erythrocytes: role of aldose reductase. Free Radic. Biol. Med. 2000, 29:642-651.
55. Terneus M.V., Brown J.M., Carpenter A.B., Valentovic M.A. Comparison of S-adenosyl-L-methionine (SAMe) and N-acetylcysteine (NAC) protective effects on hepatic damage when administered after acetaminophen overdose. Toxicology 2008, 244:25-34.
56. Tjalkens R.B., Cook L.W., Petersen D.R. Formation and export of the glutathione conjugate of 4-hydroxy-2, 3-E-nonenal (4-HNE) in hepatoma cells. Arch. Biochem. Biophys. 1999, 361:113-119.
57. Ullrich O., Grune T., Henke W., Esterbauer H., Siems W.G. Identification of metabolic pathways of the lipid peroxidation product 4-hydroxynonenal by mitochondria isolated from rat kidney cortex. FEBS Lett. 1994, 352:84-86.
58. Vila A., Tallman K.A., Jacobs A.T., Liebler D.C., Porter N.A., Marnett L.J. Identification of protein targets of 4-hydroxynonenal using click chemistry for ex vivo biotinylation of azido and alkynyl derivatives. Chem. Res. Toxicol. 2008, 21:432-444.
59. Zarkovic K. 4-Hydroxynonenal and neurodegenerative diseases. Mol. Asp. Med. 2003, 24:293-303.
60. Zheng R., Po I., Mishin V., Black A.T., Heck D.E., Laskin D.L., Sinko P.J., Gerecke D.R., Gordon M.K., Laskin J.D. The generation of 4-hydroxynonenal, an electrophilic lipid peroxidation end product, in rabbit cornea organ cultures treated with UVB light and nitrogen mustard. Toxicol. Appl. Pharmacol. 2013, 272:345-355.